1. The role of a functional variant of TYK2 in vasculitides and infections
- Author
-
Ortiz-Fernández, L., López-Mejias, R., Carmona, F. D., Castaño-Nuñez, A. L., Spanish GCA Study Group, IgAV Study Group, AAV Study Group, HIV Study Group, Lyons, P. A., Caruz, Antonio, Gónzalez-Escribano, M. F., Smith, K. G. C., González-Gay, M. A., Martin, J., and Laplana Lafaja, Marina
- Subjects
IgA vasculitis ,Hepatitis C virus ,HVI-1 ,TYK2 ,ANCA-associated vasculitis ,Giant cell arteritis - Abstract
Objective The TYK2 gene encodes a tyrosin kinase which is involved in multiple immune functions. A functional variant of this gene has been identified to play a protective role in multiple autoimmune diseases. The goal of this study was to evaluate the involvement of this variant of TYK2 in vasculitides [giant cell arteritis (GCA), ANCA-associated vasculitis (AAV) and IgA vasculitis (IgAV)] and viral infections [hepatitis C virus (HCV) and human immunodeficiency virus type I (HIV-1)]. Methods The study sample was composed of 13,745 European individuals. The genotyping was performed by Immunochip and TaqMan 5'allele discrimination assays and the allele frequencies were compared using PLINK. Results Although the results obtained did not reach the genome-wide level of significance, p-values at nominal significance were observed, suggesting that the TYK2 variant provides protection against two vasculitides: GCA (p=5.94E-3; OR (95%CI) = 0.56 (0.37-0.85) and AAV (p=6.79E-3; OR (95%CI) = 0.65 (0.47-0.89). However, this variant was not found to be associated with IgAV. No evidence was gained that the TYK2 variant confers susceptibility to HCV and HIV-1 infection. Conclusion This is the first study to propose the association between the TYK2 and both GCA and AAV. Our findings also suggest that TYK2 does not play a relevant role in IgAV or in susceptibility to HCV and HVI-1. This work was supported by the following grants: P12-BIO-1395 from Consejería de Innovación, Ciencia y Tecnología, Junta de Andalucía (Spain) and the Cooperative Research Thematic Network (RETICS) programme, RD16/0012/0013 (RIER), from Instituto de Salud Carlos III (ISCIII, Health Ministry, Madrid, Spain), FDC is recipient of a grant from the Ramon y Cajal programme (RYC-2014-16458) from the Spanish Ministry of Economy, Industry and Competitiveness. This work was supported by grants SAF2016-80125-R (Ministerio de Economía, Industria y Competitividad, Spain) to A. Caruz. RL-M is supported by the Miguel Servet I programme of the Spanish Ministry of Economy and Competitiveness through the grant CP16/00033.